Association of the Modified Albumin-Bilirubin Grade with Survival Outcomes in Esophageal Squamous Cell Carcinoma

Ann Surg Oncol. 2022 Aug;29(8):4681-4682. doi: 10.1245/s10434-022-11679-x. Epub 2022 May 9.

Authors

Yi-Min Gu^#¹, Han-Lu Zhang^#¹, Long-Qi Chen²

Affiliations

¹ Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, China.
² Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, China. drchenlq@scu.edu.cn.

^# Contributed equally.

PMID: 35527327
DOI: 10.1245/s10434-022-11679-x

No abstract available

Publication types

Editorial

MeSH terms

Albumins
Bilirubin
Carcinoma, Hepatocellular* / pathology
Esophageal Neoplasms* / pathology
Esophageal Neoplasms* / therapy
Esophageal Squamous Cell Carcinoma* / surgery
Humans
Liver Neoplasms* / pathology
Prognosis
Retrospective Studies

Substances

Albumins
Bilirubin